Portfolio

Atterx

Atterx has developed two products to fight multi-drug resistant, Gram negative bacteria. Our first product, C-1205 utilizes bacterial interference technology to prevent catheter associated urinary tract infections. Atterx has an IND on file with the FDA and is poised to enter Phase Ib clinical trials. VIEW WEBSITE